Insights into Hepatocellular Carcinoma: From Pathophysiology to Novel Therapies
Open Access
- 10 April 2024
- journal article
- editorial
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4188
Abstract
Hepatocellular carcinoma (HCC), the most common primary liver cancer, accounts for 830,180 related deaths worldwide in 2020, according to GLOBOCAN, representing the fourth leading cause of cancer-related death, with a five-year survival rate of about 18% for advanced stage, and the second leading cause in men of cancer-related mortality worldwideKeywords
This publication has 12 references indexed in Scilit:
- Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular CarcinomaInternational Journal of Molecular Sciences, 2024
- Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposalJournal of Hepatology, 2024
- Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score MatchingInternational Journal of Molecular Sciences, 2023
- Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular CarcinomaInternational Journal of Molecular Sciences, 2023
- Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel TherapiesInternational Journal of Molecular Sciences, 2023
- Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic TargetingInternational Journal of Molecular Sciences, 2023
- Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC ProgressionInternational Journal of Molecular Sciences, 2023
- Association of Differentially Altered Liver Fibrosis with Deposition of TGFBi in Stabilin-Deficient MiceInternational Journal of Molecular Sciences, 2023
- Global burden of liver disease: 2023 updateJournal of Hepatology, 2023
- The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH OxidasesBiomedicines, 2021